Twenty diabetic outpatients (12 non-insulin-treated and 8 insulin-treated) were given guar granulate in a dose of 10 g daily for two months in order to study the effect on glycaemic control and lipid levels. Mean glycosylated haemoglobin levels (HbAlc%) fell from 1.1+ 2.0% pre-guar to 10.5 + 2.2% (P< 0.001) after one month on guar and to 10.1+2.3% (P<0.0001) after two months. Following discontinuation of guar, HbA lc% rose to 11.1+2.5% (P <0.002). However, there were no significant changes in fasting blood glucose, 1 h postprandial blood glucose following a test meal, 24 h urinary glucose excretion or in lipid levels.
Introduction
Much recent attention has been focused on the improved control of diabetes which can be achieved by the use of high-carbohydrate, high-fibre diets (Simpson et al. 1981) . Although the benefit is partially derived from the high carbohydrate component (Simpson et al. 1982) , the major benefit appears to result from the high fibre content (Jenkins et al. 1976 ). The average British daily intake of fibre is around 20 g/day and some patients find difficulty in raising the fibre content to the extent required to reduce glycaemia. Guar gum, given either as granules or incorporated into food, has provided a useful means of increasing dietary fibre and improving diabetic control (Jenkins et al. 1977 , 1978 , 1979 , Aro et al. 1981 . Previous studies have used 15 g or more daily, and one study showed no significant difference in postprandial glucose levels when 10 g of guar was used in test meal experiments (Williams & James 1979) . In an attempt to examine whether small doses might improve diabetic control in outpatients, we have studied the effects of recommending Boehringer guar granules (BM. 03.003) in a dose of 5 g twice daily.
Methods
Twenty patients were recruited from the Oxford diabetic clinics. At the beginning of the study, at the end of a four-week 'run in' period, at the end of four and eight weeks on guar and four weeks after discontinuing guar, blood was taken to measure fasting glucose, glycosylated haemoglobin (HbAlc) and lipids. A 1 h postprandial blood glucose was obtained after a standard breakfast consisting of cornflakes, wholemeal bread and a boiled egg, which did not include guar and which resembled the breakfast which patients would normally eat. On each visit the patients received the same test meal. Twenty-four hour urinary glucose excretion was also measured. Ten of the patients were male and 10 were female with a mean age of 57 years. Twelve of the patients were taking oral hypoglycaemic agents and 8 were being treated with insulin. Medication was constant in all patients for six weeks prior to commencing the study and for the duration of the study unless hypoglycaemia occurred. The mean body weight was 79.8 kg and did not change significantly during the study.
Glucose was measured by a glucose-oxidase method on a Pye Unicam AC1 autoanalyser, HbAlc by isoelectric focusing (Jeppson et al. 1980) , total cholesterol by a Technicon Autoanalyser using the Liebermann Burchard reaction, cholesterol in the lipoprotein subfractions by precipitation with heparin, manganese chloride and sodium dodecyl sulphate (Burstein et al. 1970 , Ononogbu & Lewis 1976 and total triglycerides following enzymatic hydrolysis (Wahlefeld 1974) . Statistical analysis of difference was by Wilcoxon test.
Results
The means and standard deviations of the results are presented in Table 1 . Mean HbAlc% fell from 11.1% to 10.5% after one month on guar (P<0.001) and to 10.1% after two months on guar (P<0.0001). Following discontinuation of guar mean HbAlc% rose to 11.1% (P <0.002). There were no significant changes in fasting or 1 h postprandial blood glucose, total cholesterol, cholesterol in the lipoprotein subfractions, total triglycerides or in 24h urinary glucose excretion.
Four patients reduced their dose of insulin and 2 patients reduced their dose of sulphonylurea medication because of hypoglycaemia during treatment with guar. Four patients complained of mild gastrointestinal symptoms during treatment but this did not require discontinuation of guar.
Discussion
Guar is an unabsorbable gel forming fibre preparation obtained from the guar bean which has previously been shown to be effective in improving diabetic control and sometimes blood lipid metabolism in doses of greater than 15 g daily (Jenkins et al. 1977 , 1978 , 1979 , Aro et al. 1981 ). Our results demonstrate that 10 g guar daily is effective in improving diabetic control and that patients find this to be a convenient way of increasing fibre intake without a simultaneous increase in carbohydrate and energy intake. The HbAlc results underestimate the full extent of the improvement, since 6 of the 20 patients reduced their dose of hypoglycaemic therapy.
The absence of improvement in fasting or postprandial glucose on 24 h urinary glucose excretion is surprising in view of the fall in HbAlc%, but these measurements are open to many external influences in outpatient studies. No changes in lipid levels were seen. The results also suggest that short-term test meal experiments may provide a poor reflection of the true benefit ofviscous fibre supplements in diabetic patients (Williams & James 1979) . We conclude that low-dose guar is effective in improving diabetic control, with a low incidence of side effects.
